Should the dissolution sampling times for generic and reference product profiles be the same?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dissolution Sampling Times for Generic and Reference Products

A) True - The dissolution sampling times for both generic and reference product profiles should be the same.

Rationale for Identical Sampling Times

When comparing dissolution profiles between generic (test) and reference products, using identical sampling time points is a fundamental requirement for valid comparative assessment 1. This standardization is essential because:

  • Statistical comparison methods require matched time points - The similarity factor f2, which is the primary metric recommended by both FDA and EMA for dissolution profile comparison, is calculated based on dissolution rates measured at the same time points for both products 1, 2.

  • Regulatory guidelines mandate consistent methodology - Both European and US pharmacopoeia dissolution methods emphasize standardized conditions, including identical sampling times, to ensure valid quality control comparisons 3.

  • Mathematical validity depends on paired data - All statistical approaches for dissolution profile comparison (including bootstrap methods, confidence interval derivation, Mahalanobis distance, and model-dependent approaches) require dissolution measurements at identical time points to calculate meaningful differences or similarities 1.

Practical Implementation

The comparison process requires:

  • Identical dissolution apparatus and conditions - Same paddle speed (typically 75 rpm), same volume of dissolution medium (typically 900 mL), and same temperature (37 ± 0.5°C) 4.

  • Synchronized sampling schedules - Common sampling time points such as 5,10,15,20, and 30 minutes for immediate-release products, with both test and reference products sampled at these exact intervals 4.

  • Consistent analytical methods - The same spectrophotometric or analytical technique applied at each time point for both products 5, 4.

Critical Considerations

Without identical sampling times, the fundamental basis for comparison is lost - The f2 similarity factor formula specifically requires dissolution percentages at matching time points, and any deviation from this requirement invalidates the comparison 6, 1. This is particularly important when dealing with products showing large variations in individual dissolution rates, where proper statistical assessment becomes even more critical 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.